Overview
Noriko Abe practices practicing medicine in Fukushima, Japan.
Her clinical expertise encompasses Giant Mammary Hamartoma, Breast Cancer, Triple-Negative Breast Cancer, and Mastectomy.
She is actively involved in clinical research, co-authoring 21 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Noriko Abe
Is Noriko Abe a top-rated expert for Giant Mammary Hamartoma?
MediFind is an objective health platform that identifies experts based on real-world data. Noriko Abe is classified as an Experienced expert for Giant Mammary Hamartoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Noriko Abe participate in research or clinical trials?
Yes. Noriko Abe has published 21 articles and abstracts on conditions like Giant Mammary Hamartoma. You can view a list of Noriko Abe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerMs. Abe isExperienced. Learn about Breast Cancer.
- Giant Mammary HamartomaMs. Abe isExperienced. Learn about Giant Mammary Hamartoma.
- MastectomyMs. Abe isExperienced. Learn about Mastectomy.
- Triple-Negative Breast CancerMs. Abe isExperienced. Learn about Triple-Negative Breast Cancer.